Efficacy and safety of adalimumab in paediatric patients with moderate-to-severe ulcerative colitis (ENVISION I): a randomised, controlled, phase 3 study

Nicholas M. Croft, William A. Faubion, Subra Kugathasan, Jarosław Kierkuś, Frank M. Ruemmele, Toshiaki Shimizu, Nael M. Mostafa, Mary Venetucci, Tricia Finney‐Hayward, Yuri Sánchez González, Mareike Bereswill, Andreas Lazar, Dan Turner